Entos Pharmaceuticals, a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid vehicle (PLV) nucleic acid delivery platform, launched its new GMP manufacturing facility in Carlsbad, CA. The new site will support in-house production of drug substance for IND-enabling studies and clinical trials of the company’s pipeline of proprietary and partnered programs.   The facility features 20,000 sq.-ft. of dedicated manufacturing space, including a lipid ...